Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Nicardipine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1C known ✓ | Q13936 | 3/20 | 0.54 |
| ▸ | CACNA1S known ✓ | Q13698 | 2/20 | 0.49 |
| ▸ | CACNA1F known ✓ | O60840 | 1/20 | 0.49 |
| ▸ | CACNA1D known ✓ | Q01668 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.55 |
| ▸ | LMNA | P02545 | 6/20 | 0.55 |
| ▸ | TSHR | P16473 | 5/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | BLM | P54132 | 2/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.55 |
| ▸ | THPO | P40225 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | GMNN | O75496 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nicardipine SCHEMBL3972892 | 0.93 | CYP3A4 (0.63) | CYP3A4LMNATSHRCYP1A2CYP2C9 | |
| Diltiazem SCHEMBL9069266 | 0.85 | CYP3A4 (0.63) | CYP3A4LMNATSHRCYP1A2CYP2C9 | |
| Nicardipine SCHEMBL9449513 | 0.83 | LMNA (0.80) | CYP3A4LMNATSHRCYP1A2CYP2C9 | |
| Verapamil SCHEMBL9352908 | 0.81 | CYP3A4 (0.41) | CYP3A4LMNATSHRCYP1A2CYP2C9 | |
| Diltiazem SCHEMBL6789503 | 0.77 | CACNA1S (0.62) | CYP3A4LMNATSHRCYP1A2CYP2C9 | |
| Diltiazem SCHEMBL7859531 | 0.77 | CACNA1S (0.69) | CYP3A4LMNATSHRCYP1A2CYP2C9 | |
| SCHEMBL11852673 | 0.76 | CACNA1C (0.74) | CYP3A4LMNATSHRCYP1A2CYP2C9 | |
| Nicardipine SCHEMBL7625913 | 0.76 | CYP1A2 (0.87) | CYP3A4LMNATSHRCYP1A2CYP2C9 | |
| Hydrochloric Acid SCHEMBL11402267 | 0.76 | LMNA (0.85) | CYP3A4LMNATSHRCYP1A2CYP2C9 | |
| SCHEMBL9765780 | 0.75 | CACNA1C (0.84) | CYP3A4LMNATSHRCYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5576014-A | MIXTURE OF SACCARIDE GRANULES HAVING LOW MOLDABILITY AND HIGH MOLDABILITY | YAMANOUCHI PHARMACEUTICAL CO., LTD (JP) | 1996-11-19 | — | — | US | disclosed |